PPP1R14A
Protein phosphatase 1 regulatory subunit 14A
Also known as: CPI-17, PP14A_HUMAN, PPP1INL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96A00
- Gene
- PPP1R14A
- Ensembl
- ENSG00000167641
- Chromosome
- 19
- Canonical length
- 147 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
The protein encoded by this gene belongs to the protein phosphatase 1 (PP1) inhibitor family. This protein is an inhibitor of smooth muscle myosin phosphatase, and has higher inhibitory activity when phosphorylated. Inhibition of myosin phosphatase leads to increased myosin phosphorylation and enhanced smooth muscle contraction. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Sep 2011]
Canonical amino-acid sequenceUniProt
147 residues, UniProt reviewed canonical sequence.
>Q96A00|PPP1R14A
1 MAAQRLGKRV LSKLQSPSRA RGPGGSPGGL QKRHARVTVK YDRRELQRRL DVEKWIDGRL
61 EELYRGMEAD MPDEINIDEL LELESEEERS RKIQGLLKSC GKPVEDFIQE LLAKLQGLHR
121 QPGLRQPSPS HDGSLSPLQD RARTAHPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PPP1R14A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 1,610 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 1,610 nTPM
- spinal cord: 861 nTPM
- colon: 552 nTPM
- midbrain: 501 nTPM
- urinary bladder: 396 nTPM
- hippocampal formation: 344 nTPM
Single-cell type
- megakaryocytes: 1,156 nCPM
- vascular smooth muscle cells: 1,021 nCPM
- hepatic stellate cells: 994 nCPM
- smooth muscle cells: 957 nCPM
- decidual stromal cells: 649 nCPM
- peritubular myoid cells: 596 nCPM
Immune cell
- memory B-cell: 301 nTPM
- naive B-cell: 286 nTPM
- plasmacytoid DC: 248 nTPM
- myeloid DC: 45 nTPM
- total PBMC: 22 nTPM
- basophil: 12 nTPM
Brain region
- white matter: 896 nTPM
- medulla oblongata: 748 nTPM
- thalamus: 662 nTPM
- basal ganglia: 616 nTPM
- cerebellum: 577 nTPM
- midbrain: 576 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0.13
- gnomAD missense Z
- 0.56
- DepMap mean gene effect
- 0
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PPP1R14A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PPP1R14A as an antibody target. Whether an autoantibody or antibody against PPP1R14A could matter depends on whether native PPP1R14A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PPP1R14A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PPP1R14A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...